NEUROENDOCRINE CANCER
Clinical trials for NEUROENDOCRINE CANCER explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE CANCER trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for Tough-to-Treat neuroendocrine cancers
Disease control Recruiting nowThis early-stage study is testing a new drug called BL-M14D1 in 120 patients with advanced small cell lung cancer and other neuroendocrine cancers that have spread and stopped responding to standard treatments. The main goals are to find the safest dose and see how the body proce…
Matched conditions: NEUROENDOCRINE CANCER
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for tough cancers: early trial tests promising drug
Disease control Recruiting nowThis study is testing a new drug called ZG006 for people with advanced small cell lung cancer or other neuroendocrine cancers. The first part aims to find a safe dose, and the second part will see how well the drug works at controlling the cancer. Researchers will measure how man…
Matched conditions: NEUROENDOCRINE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
New scan lights up Hard-to-Find cancer tumors
Diagnosis Recruiting nowThis study is testing a new type of PET scan designed to find neuroendocrine cancer tumors more accurately. The scan uses a special tracer that attaches to a protein called DLL3, which is often found on these cancer cells. Researchers will compare this new scan to standard imagin…
Matched conditions: NEUROENDOCRINE CANCER
Phase: NA • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Diagnosis
Last updated Apr 01, 2026 21:56 UTC